Physician profile
Michael Maher Kattula
NPI 1679140008
$3,151.51
in general payments reported to CMS, 2019-2025
17 companies · $2,223 in 2025
The $2,223 reported for 2025 was more than what 85% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $928 · 2025: $2,223.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,000 · Education: $151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,000.07 |
| Education | $151.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $562.21 | 2024-2025 | Lifevest |
| Boston Scientific Corporation | $310.00 | 2024-2025 | Emblem Mri S-Icd, Lux-Dx Insertable Cardiac Monitor, Avvigo Guidance System |
| Asahi Intecc USA, INC. | $277.80 | 2025 | Asahi Coronary Wires |
| Cardiva Medical, INC. | $274.40 | 2024-2025 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
| Stryker Corporation | $252.79 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Clottriever Bold Catheter |
| Astrazeneca Pharmaceuticals LP | $222.31 | 2024-2025 | |
| Kestra Medical Technology Services, INC. | $218.57 | 2024-2025 | Assure Wcd |
| Abbott Laboratories | $210.96 | 2024-2025 | Optis, Coroflow, Cardiomems |
| Abiomed | $200.50 | 2024-2025 | Impella |
| Penumbra, INC. | $162.77 | 2025 | Indigo System |
| Shockwave Medical, INC | $145.77 | 2025 | |
| Bridgebio Pharma, INC. | $107.61 | 2025 | Attruby |
| E.R. Squibb & Sons, L.L.C. | $76.59 | 2025 | |
| Teleflex LLC | $53.92 | 2025 | Turnpike, Trapliner, Guideliner |
| Novartis Pharmaceuticals Corporation | $40.84 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $19.71 | 2024 | Kengreal |
| Becton, Dickinson and Company | $14.76 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Kattula listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.